{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69539-075",
      "generic_name": "Deferasirox",
      "labeler_name": "MSN LABORATORIES PRIVATE LIMITED",
      "brand_name": "Deferasirox",
      "active_ingredients": [
        {
          "name": "DEFERASIROX",
          "strength": "360 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69539-075-30",
          "description": "30 TABLET in 1 BOTTLE (69539-075-30)",
          "marketing_start_date": "20191120",
          "sample": false
        },
        {
          "package_ndc": "69539-075-99",
          "description": "1000 TABLET in 1 BOTTLE (69539-075-99)",
          "marketing_start_date": "20191120",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "MSN LABORATORIES PRIVATE LIMITED"
        ],
        "rxcui": [
          "1607784",
          "1607792",
          "1607796"
        ],
        "spl_set_id": [
          "0354cbc7-9b32-4513-976a-2ef2da39b6b3"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0369539074303",
          "0369539075997",
          "0369539074990",
          "0369539073993",
          "0369539075300",
          "0369539073306"
        ],
        "nui": [
          "N0000000144",
          "N0000175522",
          "N0000185506",
          "N0000187062",
          "N0000182138"
        ],
        "pharm_class_moa": [
          "Iron Chelating Activity [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]",
          "Cytochrome P450 2C8 Inhibitors [MoA]",
          "Cytochrome P450 1A2 Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Iron Chelator [EPC]"
        ],
        "unii": [
          "V8G4MOF2V9"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "da168049-e499-4563-afe8-82ae754ed640",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20191120",
      "product_id": "69539-075_da168049-e499-4563-afe8-82ae754ed640",
      "application_number": "ANDA210945",
      "brand_name_base": "Deferasirox",
      "pharm_class": [
        "Cytochrome P450 1A2 Inhibitors [MoA]",
        "Cytochrome P450 2C8 Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inducers [MoA]",
        "Iron Chelating Activity [MoA]",
        "Iron Chelator [EPC]"
      ]
    }
  ]
}